Ben Tre Pharmaceutical JSC (HOSE:DBT)

Market Cap	246.03B
Revenue (ttm)	839.79B
Net Income (ttm)	13.96B
Shares Out	21.97M
EPS (ttm)	635.45
PE Ratio	17.63
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,000
Average Volume	4,146
Open	11,200
Previous Close	11,200
Day's Range	11,200 - 11,200
52-Week Range	9,907 - 12,150
Beta	0.57
RSI	50.40
Earnings Date	Feb 3, 2026

About HOSE:DBT

Ben Tre Pharmaceutical Joint Stock Company manufactures, distributes, and sells pharmaceutical products in Vietnam and internationally. The company offers drugs in injectable, infusion, pill, and lotion forms. The company provides products covering various therapeutic areas, including central nervous system, respiratory system, endocrinology, obstetrics and gynecology, anti-allergic, cardiovascular, antibiotics, anti-fungal, anti-viral, musculoskeletal, vitamins and minerals, digestive, hepatobiliary and urinary, pain relief, fever reducer, ant...

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 774
• Stock Exchange: Ho Chi Minh Stock Exchange
• Ticker Symbol: DBT

Financial Performance

In 2024, HOSE:DBT's revenue was 868.41 billion, an increase of 7.00% compared to the previous year's 811.62 billion. Earnings were 13.49 billion, an increase of 4.02%.